The Off-Ramp: Novel Diabetes Reversal Program Bolsters Support of Nonpharmacological Disease Management

The prevalence of diabetes continues to rise and shows no signs of slowing down, according to a 2021 report from IDF that estimates 537 million people worldwide live with diabetes—approximately 10% of the global population.¹ If the reports predictions hold true, these figures could reach 643 million in the next 5 years, and surpass 780 million by 2045. At the time, diabetes led to $966 billion in health care expenditure, with IDF projections anticipating a future where the associated health care costs exceed $1.4 trillion.